Predictmedix Inc. announced a purchase order from one of the Government hospital groups in India, MGM Healthcare, for the company's AI-powered Safe Entry Stations. The purchase order was followed by the recently completed third-party, 400-patient clinical study conducted by MGM Healthcare in which the scope was to determine the effectiveness of Predictmedix's AI-powered screening technology. Safe Entry is a comprehensive and global risk management solution that utilizes a fully patented system to rapidly and autonomously screen for individuals' key vitals.

The Safe Entry Station is a walk-thru system where an individual stands in front of the unit for 2-3 seconds while multi-spectral imaging cameras gather the necessary information to determine the physiological state of an individual. parameters like temperature, heart rate, and respiration rate are collected non-invasively and the AI/ML algorithms compute a result. Vitals hold key insight into an individual's state, whether they're dealing with health complications, influenza, fatigue or even impairment.

Safe Entry does not capture or store personal identity information, ever. MGM Healthcare is a prominent group of medical universities in India, comprising multiple hospitals across the country. Known for their facilities and commitment to delivering exceptional healthcare services, MGM Healthcare has chosen to deploy five Safe Entry Stations to screen patients for infectious diseases and triage purposes.

This purchase order represents a substantial investment, with a value of approximately CAD 500,000 spread over a three-year period. By improving patient care and streamlining operations, Safe Entry offers a comprehensive solution for healthcare facilities looking to enhance their capabilities.